Theratechnologies Inc T.TH

Pricing failure

[Trogarzon]

It's a strategy... let it plummet until th1902 is priced as a total writoff and then put out your not so good news and praise your 80m in sales and you 10% line of credit... that's what is happening.

[realitycheck4u]

This post has been removed in accordance with Community Policy

[canadapiet]

realitycheck4u - (7/7/2022 11:26:20 AM) RE:Pricing failure Well, we do agree they are letting it plummet. Im not a fan of that 'strategy', and this is due to not saying anything, and when they do say something, there is holes in it.  Did any ph1a patients move to ph1b?  Yes? No?  We do not know.  Why did ph1a go so slowly?  We don't know.

[Wino115]

I would suggest those very simple questions, addressed to whom you want to answer it, be submitted by all so that they have to answer them.  It seems they look at all the questions, try to lump some together, and they don't seem to take a lot of questions from any one person.  We've seen reports here from some where one of their 3 or 4 questions gets picked up.   So it

[PWIB123]

@Wino115 What's the best way to submit questions?  I believe I've heard them take written questions during the earnings call.  I won't be around, and would like to support this initiative by submitting in advance.  Is it best to email IR?

[jeffm34]

Patients have been getting TH1902 for 16 months now and still no sign or hint of efficacy.  The longer the silence continues the lower the share price.   

[SPCEO1]

You are looking at that incorrectly. They may indeed have seen signs of efficacy in the phase 1a. But since the phase 1a was looking only at safety, signs of efficacy were not even being monitored as they are in the phase 1b. So, they may have seen indications the drug works in phase 1a but those patients were not likely being scanned after six and twelve weeks and may not even have been on the

[jeffm34]

That's my point. We shouldn't be sitting here 16 months out with no suitable patient data to evaluate efficacy. The entire phase 1A and 1B was originally scheduled to be finished by now. 

[SPCEO1]

Yes, it would have been very nice if the phase 1a went smoother than it apparently did so that so much time was not lost. But drug trials, particularly ones that are utilizing incredily sick people to test on, are going to be more challenging to complete than most drug trials and most drug trials take longer than expected anyway. The next challenge for the phase 1b, as Wino has pointed out, is

[jeffm34]

my post from Feb 2021 and SPCEO1 response. I think you have been overly optimistic in the abilities of management  jeffm34 (73) User Actions   February 10, 2021 - 01:30 PM 58 Reads  Post# 32526903 RE:RE:RE:RE:RE:RE:RE:Short interest on THTX plummets It will be several months before the first patient is dosed. It

[canadapiet]

I'm wondering...... All those years, you (or your "fund") are invested in this company with a lot of money, because you did your dd and thought it was a good investing! Over the years, this company did deliver with their products but the earnings didn't follow......!! Now, they are changing their "core" (hiv) to 2  new possibilities, oncology and Nash. Nash is on

[Trogarzon]

Let's get use to not knowing anything about Th1902.. like Nash it's a time buying mechanism for their inflated salaries.  They'll ding somthing else to push to some newborn imbecile in a few months... and ever after..

[SPCEO1]

If TH-1902 is shown to work, money to fund further research on it and the many varieties of treatments it will spawn will not be a problem. But we need to hear an affirmative on the proof of concept question first.  As I made abundantly clear, the ONO was a huge setback in my relationship with TH management. I talk to them but far less frequently but am still supportive. Theyare really